# LHC-CIDI-5 in Hong Kong

> **NCT06804525** · — · RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 2500 (estimated)

## Conditions studied

- Major Depressive Episode (MDE)
- Major Depressive Disorder (MDD)
- Persistent Depressive Disorder (PDD)
- Suicidal Ideation
- Suicidal Plan
- Suicidal Attempt
- Suicidal Gesture
- Nonsuicidal Self-Injury
- Manic Episode
- Hypomanic
- Bipolar I Disorder
- Bipolar Sub Disorder
- Bipolar II Disorder
- Generalized Anxiety Disorder (GAD)
- Intermittent Explosive Disorder (IED)
- Panic Attack
- Panic Disorder
- Obsessive-Compulsive Disorder (OCD)
- Posttraumatic Stress Disorder (PTSD)
- PCL-SC PTSD
- PCL-5 PTSD
- Alcohol Use Disorder (AUD)
- Substance Use Disorder (SUD)

## Interventions

- **DIAGNOSTIC_TEST:** CIDI-5
- **DIAGNOSTIC_TEST:** LHC-CIDI-5

## Key facts

- **NCT ID:** NCT06804525
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-18
- **Primary completion:** 2026-09
- **Final completion:** 2027-04
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06804525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06804525, "LHC-CIDI-5 in Hong Kong". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06804525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*